Log in

Unplanned presentations of cancer outpatients: a retrospective cohort study

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

As a result of the growing cancer incidence and the increasing trend towards chemotherapy treatment, a higher number of cancer outpatients ask for unplanned visits. This study aimed to describe the nature and magnitude of this phenomenon and to identify risk factors for repeated unplanned presentations and hospital admission.

Methods

Unplanned consultations (2,811) of 1,431 cancer patients who accessed our acute oncology clinic over a 2-year period were reviewed. Demographics, clinical variables and reason(s) for presentation were all recorded. Recurrent event survival analysis was used to evaluate the relation of potential predictors to the two outcome events repeated presentations and hospitalization. A stratified Cox proportional hazard model was used.

Results

Of 1,431 patients, 625 (43 %) received chemotherapy during the 90 days before the unplanned visit. Pain (27.7 %), fatigue (17.6 %), dyspnoea (13.8 %), fever (11.5 %) and gastrointestinal problems (31 %) were reported frequently. The time interval since the last chemotherapy was significantly related to the rate of repeated presentation. Two hundred and nine patients (7 %) were hospitalized after an unplanned presentation. Number of symptoms and selected toxicities, along with distance from the hospital, were all predictors for hospitalization.

Conclusions

The management of unscheduled presentations of cancer outpatients is becoming crucial to avoid inappropriate selection for hospital admission and interferences with the ordinary work plan, improving quality of oncology services.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Berrino F, De Angelis R, Sant M et al (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 8:773–783

    Article  PubMed  Google Scholar 

  2. De Angelis R, Grande E, Inghelmann R et al (2007) Cancer prevalence estimates in Italy from 1970 to 2010. Tumori 93:392–397

    PubMed  Google Scholar 

  3. McKenzie H, Hayes L, White K et al (2011) Chemotherapy outpatients' unplanned presentations to hospital: a retrospective study. Support Care Cancer 19:963–969

    Article  PubMed  Google Scholar 

  4. Mayer DK, Travers D, Wyss A, Leak A, Waller A (2011) Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina. J Clin Oncol 29:2683–2688

    Article  PubMed  Google Scholar 

  5. Diaz-Couselo FA, O'Connor JM, Nervo A et al (2004) Nonscheduled consultation in oncologic patients. How many of them are true emergencies? An observational prospective study. Support Care Cancer 12:274–277

    Article  PubMed  CAS  Google Scholar 

  6. Aprile G, Ramoni M, Keefe D, Sonis S (2009) Links between regimen-related toxicities in patients being treated for colorectal cancer. Curr Opin Support Palliat Care 3:50–54

    Article  PubMed  Google Scholar 

  7. Cheung WJ, Le LW, Zimmermann C (2009) Symptom clusters in patients with advanced cancers. Support Care Cancer 17:1223–1230

    Article  PubMed  Google Scholar 

  8. Bang SM, Park SH, Kang HG et al (2005) Changes in quality of life during palliative chemotherapy for solid cancer. Support Care Cancer 13:515–521

    Article  PubMed  Google Scholar 

  9. Hovan AJ, Williams PM, Stevenson-Moore P et al (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18:1081–1087

    Article  PubMed  Google Scholar 

  10. Pinto C, Barone CA, Girolomoni G et al (2011) Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy. Oncologist 16:228–238

    Article  PubMed  Google Scholar 

  11. Bennett CL, Calhoun EA (2007) Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Oncologist 12:478–483

    Article  PubMed  Google Scholar 

  12. Calhoun EA, Chang CH, Welshman EE, Fishman DA, Lurain JR, Bennett CL (2001) Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients. Oncologist 6:441–445

    Article  PubMed  CAS  Google Scholar 

  13. Hassett MJ, O'Malley AJ, Pakes JR, Newhouse JP, Earle CC (2006) Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 98:1108–1117

    Article  PubMed  Google Scholar 

  14. Wagner-Johnston ND, Carson KA, Grossman SA (2010) High outpatient pain intensity scores predict impending hospital admissions in patients with cancer. J Pain Symptom Manage 39:180–185

    Article  PubMed  Google Scholar 

  15. Hernandez C, Jansa M, Vidal M et al (2009) The burden of chronic disorders on hospital admissions prompts the need for new modalities of care: a cross-sectional analysis in a tertiary hospital. QJM 102:193–202

    Article  PubMed  CAS  Google Scholar 

  16. Elting LS, Lu C, Escalante CP et al (2008) Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol 26:606–611

    Article  PubMed  Google Scholar 

  17. Whitmer KM, Pruemer JS, Nahleh ZA, Jazieh AR (2006) Symptom management needs of oncology outpatients. J Palliat Med 9:628–630

    Article  PubMed  Google Scholar 

  18. Farncombe ML (1994) Ambulatory supportive care for the cancer patient. Curr Opin Oncol 6:335–339

    Article  PubMed  CAS  Google Scholar 

  19. Prentice RL, Williams BJ, Peterson AV (1981) On the regression analysis of multivariate failure time data. Biometrika 68:373–379

    Article  Google Scholar 

  20. Serraino D, Bidoli E, De Paoli A, De Dottori M, Zucchetto A, Zanier L (2009) Cancer in Friuli Venezia Giulia. Incidence, survival and prevalence: 1995-2005. Registro tumori del Friuli Venezia Giulia. Litho Stampa, Udine

    Google Scholar 

  21. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27:2758–2765

    Article  PubMed  Google Scholar 

  22. Peppercorn JM, Weeks JC, Cook EF, Joffe S (2004) Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet 363:263–270

    Article  PubMed  Google Scholar 

  23. Ioannidis JP, Lau J (2001) Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 285:437–443

    Article  PubMed  CAS  Google Scholar 

  24. Goudas LC, Bloch R, Gialeli-Goudas M, Lau J, Carr DB (2005) The epidemiology of cancer pain. Cancer Invest 23:182–190

    Article  PubMed  Google Scholar 

  25. Storey DJ, Waters RA, Hibberd CJ et al (2007) Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study. Ann Oncol 18:1861–1869

    Article  PubMed  CAS  Google Scholar 

  26. Morrison V, Henderson BJ, Zinovieff F et al (2011) Common, important, and unmet needs of cancer outpatients. Eur J Oncol Nurs 2011. doi:10.1016/j.ejon.2011.04.004

  27. Kleeberg UR, Tews JT, Ruprecht T, Hoing M, Kuhlmann A, Runge C (2005) Patient satisfaction and quality of life in cancer outpatients: results of the PASQOC study. Support Care Cancer 13:303–310

    Article  PubMed  CAS  Google Scholar 

  28. Hassett MJ, Rao SR, Brozovic S et al (2011) Chemotherapy-related hospitalization among community cancer center patients. Oncologist 16:378–387

    Article  PubMed  Google Scholar 

  29. Uramoto H, Iwashige A, Kagami S, Tsukada J (2007) Prediction of emergency hospitalization of outpatients receiving cancer chemotherapy. Anticancer Res 27:1133–1136

    PubMed  Google Scholar 

Download references

Acknowledgments

We acknowledge and deeply thank Mrs. Paola Costantini, Mrs. Manuela De Apollonia and Mrs. Raffaela Donato for their generous assistance with study coordination, and all the other nurses at the Department of Medical Oncology, University Hospital, Udine, Italy, who contributed to data collection. This study was in part presented as oral communication at the 2011 MASCC Annual Meeting, Athens, Greece.

Conflict of interest

None declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Aprile.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aprile, G., Pisa, F.E., Follador, A. et al. Unplanned presentations of cancer outpatients: a retrospective cohort study. Support Care Cancer 21, 397–404 (2013). https://doi.org/10.1007/s00520-012-1524-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-012-1524-6

Keywords

Navigation